Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 2025

FDA

Sucralfate

Approved 14 Apr 2025OralSuspension

The FDA lists this product in 14 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: SUCRALFATE 1GM/10ML

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

SUCRALFATE 1GM/10ML · SuspensionANDA212769-001 · Discontinued
SUCRALFATE 1GM/10ML · SuspensionANDA216726-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA211884-001 · Prescription
SUCRALFATE 1GM · TabletANDA215576-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA212141-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA213549-001 · Prescription
SUCRALFATE 1GM · TabletANDA215705-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA216474-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA217126-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionThis page
SUCRALFATE 1GM · TabletANDA074415-001 · Prescription
SUCRALFATE 1GM · TabletANDA070848-001 · Prescription
SUCRALFATE 1GM/10ML · SuspensionANDA209356-001 · Prescription
SUCRALFATE 1GM/10ML · Suspension

At a glance

Brand name: Sucralfate
Route: Oral
Dosage form: Suspension
Applicant: Padagis US
Status: Prescription
FDA approval: 14 Apr 2025
Application: ANDA211780-001

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA212913-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA211780.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.